Instapath Awarded Small Business Innovation Research Phase II Award from National Science Foundation


Houston, TX, March 9, 2021 – Instapath has received a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $1,000,000to continue development of an integrated technology platform that automates the entire process of tissue histology and creates digital pathology images.


The biotechnology company makes Luci, a digital microscope that provides histology-equivalent images of excised cancer biopsies within seconds. Luci obviates the need for fixing and cutting pathology samples. Instapath’s goal is to help cancer patients get a more accurate and efficient diagnosis, so they can begin receiving proper treatment as quickly as possible.


“We are grateful to receive phase II of the prestigious SBIR grant from the NSF,” said Dr. Mei Wang, CEO of Instapath. “This award is a reflection of the team’s dedication toward delivering a faster, more exact solution for biopsy diagnosis to cancer patients.”


Instapath aims to further develop new strategies to automate the acquisition of microscopic images from pathology samples, while simultaneously improving both


speed and image quality to meet clinical needs. The project will culminate in verification and clinical validation of the integrated Luci system for point-of-care biopsy evaluation.


About Instapath: Built on the vision of better patient outcomes, Instapath was founded


in 2017 by engineers and scientists to enable patients to immediately know their cancer diagnosis. The team’s mission is to develop fast and easy-to-use digital pathology technology so diagnoses can be made in minutes instead of days. To learn more about Instapath and our technology, visit https://instapathbio.com/ or contact us at info@instapathbio.com


About America’s Seed Fund: America’s Seed Fund powered by the National Science Foundation (NSF) awards $200 million annually to startups and small businesses, transforming scientific discovery into products and services with commercial and societal impact. Startups working across almost all areas of science and technology can receive up to $2 million in non-dilutive funds to support research and development (R&D),helping de-risk technology for commercial success. America’s Seed Fund is congressionally mandated through the Small Business Innovation Research (SBIR) program. The NSF is an independent federal agency with a budget of about $8.5 billion that supports fundamental research and education across all fields of science and engineering. For more information, visit seedfund.nsf.gov.


© 2021 Instapath Inc.   This device is not approved by the FDA for clinical use.